Comparative Pharmacology
Head-to-head clinical analysis: DELFLEX W DEXTROSE 4 25 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 1 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DELFLEX W DEXTROSE 4 25 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 1 5 IN PLASTIC CONTAINER.
DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER vs DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Peritoneal dialysis solution with dextrose as osmotic agent; removes solutes and water across peritoneal membrane via diffusion and ultrafiltration.
Dianeal PD-2 with Dextrose 1.5% is a peritoneal dialysis solution. Dextrose acts as an osmotic agent to create an osmotic gradient across the peritoneal membrane, facilitating the removal of waste products (urea, creatinine) and excess fluid from the blood into the peritoneal cavity, which is then drained out.
Intraperitoneal administration: 2 L per exchange, typically 4 exchanges daily (continuous ambulatory peritoneal dialysis). Dextrose 4.25% solution used for ultrafiltration. Dose adjusted based on body size and fluid status.
Intraperitoneal: 2-2.5 L per exchange, 4 exchanges per day (continuous ambulatory peritoneal dialysis).
None Documented
None Documented
Not applicable as a drug; dextrose is rapidly metabolized; plasma half-life of glucose ~1.5-2 hours; continuous reabsorption in dialysis prevents accumulation.
Not applicable; dextrose utilization is capacity-limited with half-life of ~1.5 hours in normal circulation. In peritoneal dialysis, the osmotic effect declines over dwell time (2-4 hours) as dextrose is absorbed.
Peritoneal dialysis; effectively removed via peritoneal membrane during dialysis exchanges; systemic absorption of dextrose minimal; elimination primarily through dialysate outflow; renal excretion negligible in anuria.
Dextrose is completely metabolized via glycolysis and the citric acid cycle to carbon dioxide and water; <1% excreted unchanged in urine. Osmotic agent effect terminated by peritoneal absorption and systemic metabolism.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution